Skip to main content

Clifford Chance
Dominic Ross

Dominic Ross

Partner

Partner
Dominic Ross

Dominic Ross is a Partner in Clifford Chance's corporate department specialising in public and private M&A as well as a wide range of board advisory matters, including corporate governance and shareholder activism defence.

Dominic has extensive experience advising corporates and financial sponsors on complex and strategically significant cross-border transactions, with a particular focus on the healthcare, defence and consumer goods and retail sectors.

  • S&P Global on its agreement to acquire With Intelligence, a leading source of private markets data, insights and analytics, for US$1.8 billion from Motive Partners and a number of other sellers
  • EDF Energy Customers on its takeover of EV charging business Pod Point Group Holdings PLC
  • ED&F Man Holdings in relation to an exclusive agreement to dispose of ED&F Man Commodities’ three business units: Volcafe (coffee), ED&F Man Liquid Products (molasses, animal feeds and fish oil) and ED&F Man Sugar to Hartree Partners, LP
  • A large global aerospace company on its defence against an aggressive shareholder activist
  • Mondelēz International on the sale of its developed-market chewing gum business in the US, Canada and Europe to leading European gum and confectionery maker Perfetti Van Melle Group for US$1.350 billion
  • Avast plc, the FTSE100 cybersecurity service provider, on its US $9.2 billion takeover by NortonLifeLock,Inc
  • Triton on its £1.3 billion takeover of Clinigen Group plc
  • Advanz Pharma on its US $846 million takeover by Nordic Capital
  • Aroundtown SA on its €1.57 billion hostile joint takeover with CPI Property Group of Globalworth
  • Morrisons on its long-term commercial arrangements with Amazon and Ocado
  • Avon Protection plc on over $500 million of acquisitions and disposals, including:
    - its acquisition of 3M's ballistic protection business
    - its disposal of its Milkrite business to DeLaval
  • Takeda on multiple portfolio disposals including:
    - the US$670 million divestment to Orifarm in Europe;
    - the US$825 million divestment to Hypera Pharma in Brazil, Mexico and certain other Latin American countries;
    - the US$660 million divestment to STADA in Russia, Georgia, and a number of countries from within the CIS; and
    - the US$200 million divestment to Acino in a number of EMEA countries.
  • Gala Coral on its £2.3 billion merger with Ladbrokes plc
  • Berendsen plc on its £2.2 billion takeover by French listed company Elis SA
  • Xchanging plc on its competitive takeover, ultimately won by Computer Sciences Corporation
  • Cape plc on its takeover by Altrad 
  • URS Corporation on its takeover of Scott Wilson plc
  • Strategic Value Partners on its €750 million takeover of Pfleiderer Group S.A

 Certain matters may have been worked on prior to joining Clifford Chance

News and client work

View all news and client work featuring Dominic Ross

Contact details

Career & qualifications

  • University of Exeter (LL.B) 2003
  • Admitted as solicitor in England & Wales 2007
  • Partner at Ashurst LLP 2015
  • Partner at White & Case LLP 2018
  • Joined Clifford Chance as a Partner in 2022